Porton Pharma Solutions Ltd.
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, Porton Pharma Solutions Ltd. disclosed greenhouse gas emissions of 109.7K tCO2e/year (Scope 1 and 2). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
109.7K tCO2e/year (Scope 1 and 2)
2023
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023 | 109.7K tCO2e/year (Scope 1 and 2) |
| 2022 | 20.1M tons of CO2e (Scope 1 and 2 excludes Suzhou) |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Implemented a Climate Change Program and submitted commitment to the Science Based Targets initiative (SBTi) to develop near-term greenhouse gas emission reduction targets.
- Chongqing Changshou Plant implemented a project for the waste heat utilization of waste solvent steam, reducing greenhouse gas emissions by 176 tons of CO2e per year.
- In a project for a multinational pharmaceutical company, biocatalysis technology resulted in a doubling of total yield, a two-thirds reduction in PMI, a 95% reduction in solid waste, and an 80% reduction in organic solvent waste.
🎯 Climate & Sustainability Targets
🔜 Short-term
- Develop near-term targets for reducing greenhouse gas emissions over the next 24 months (SBTi).
🌱 ESG Focus Areas
Green developmentBuilding a healthy societyPromoting common progressEnhancing corporate governance